These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 27482825

  • 1. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J, Petruželková L, Flekač M, Pelcl T, Matoulek M, Daňková M, Škrha J, Svačina Š, Prázný M.
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [Abstract] [Full Text] [Related]

  • 2. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J, Petruželková L, Grunberger G, Hásková A, Flekač M, Matoulek M, Mikeš O, Pelcl T, Škrha J, Horová E, Škrha J, Parkin CG, Svačina Š, Prázný M.
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [Abstract] [Full Text] [Related]

  • 3. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S, Smith-Palmer J, Valentine WJ, Cook M, Jethwa M, de Portu S, Pickup JC.
    J Med Econ; 2016 Jan; 19(3):236-42. PubMed ID: 26510389
    [Abstract] [Full Text] [Related]

  • 4. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S, Bonnemaison-Gilbert E, Leutenegger E, Barat P.
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R, Alsubaiee M, Alqarni A, Saleh Y, Aljaser S, Salam A, Eledrisi M.
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [Abstract] [Full Text] [Related]

  • 6. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.
    Ann Intern Med; 2012 Sep 04; 157(5):336-47. PubMed ID: 22777524
    [Abstract] [Full Text] [Related]

  • 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.
    Health Technol Assess; 2016 Feb 04; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [Abstract] [Full Text] [Related]

  • 8. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L.
    Acta Diabetol; 2021 Apr 04; 58(4):401-410. PubMed ID: 32789691
    [Abstract] [Full Text] [Related]

  • 9. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D.
    Diabetes Technol Ther; 2017 Jun 04; 19(S3):S25-S37. PubMed ID: 28585879
    [Abstract] [Full Text] [Related]

  • 10. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR, Peyrot M.
    J Diabetes Sci Technol; 2009 Nov 01; 3(6):1402-10. PubMed ID: 20144395
    [Abstract] [Full Text] [Related]

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S, Peter Chase H.
    Int J Clin Pract Suppl; 2011 Feb 01; (170):76-82. PubMed ID: 21323816
    [Abstract] [Full Text] [Related]

  • 12. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
    Moreno-Fernandez J, Gómez FJ, Gálvez Moreno MÁ, Castaño JP.
    J Diabetes Res; 2016 Feb 01; 2016():4171789. PubMed ID: 28004007
    [Abstract] [Full Text] [Related]

  • 13. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.
    Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Hamblin PS, O'Connell MA, Rodda C, Teede H, O'Neal DN.
    Diabetes Technol Ther; 2011 Feb 01; 13(2):105-9. PubMed ID: 21284476
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM, Marín Carrillo LF, Muñoz Velandia OM, Rondón Sepúlveda MA, Arévalo Correa CM, Mora Garzón E, Cuervo Diaz MC, Henao Carrillo DC.
    Diabetes Technol Ther; 2017 Feb 01; 19(2):109-114. PubMed ID: 28001445
    [Abstract] [Full Text] [Related]

  • 18. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J, Gomez FJ, Gazquez M, Pedroche M, García-Manzanares A, Tenias JM, Benito P, Gomez IR.
    Diabetes Technol Ther; 2013 Jul 01; 15(7):596-600. PubMed ID: 23631604
    [Abstract] [Full Text] [Related]

  • 19. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
    Roze S, Smith-Palmer J, de Portu S, Özdemir Saltik AZ, Akgül T, Deyneli O.
    Diabetes Technol Ther; 2019 Dec 01; 21(12):727-735. PubMed ID: 31509715
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A, Rossi MC, D'Ostilio D, Delbaere A, de Portu S, Roze S.
    Nutr Metab Cardiovasc Dis; 2018 Jul 01; 28(7):707-715. PubMed ID: 29753586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.